Analysis of indicators of 24-h holter monitoring ECG in elderly hypertensive patients with atrial fibrillation

##plugins.themes.bootstrap3.article.main##

Л. В. Бевзюк
Л. М. Єна

Abstract

The prevalence of essential hypertension (EH) defines its significance as the most important population – based risk factor for development  of atrial fibrillation (AF). The heart morphological remodelling – the   development of left ventricular hypertrophy and its diastolic dysfunc  tion, the increase of left atrial sizes is associated with increased risk for the development of atrial and ventricular arrhythmias.

The objective: to estimate the rate of arrhythmias in elderly hypertensive patients depending on the form of atrial fibrillation (AF) – persistent or permanent.

Patients and methods. Doppler echocardiography and Holter monitoring ECG were investigated in 140 patients aged 60–74 years. The  were 20 patients with uncomplicate EH, 60 patients with persistent (PersAF) and 60 – wits permanent (PermAF) AF.

Results. It was established that patients EH have high frequency of single ventricular extrasystoles. The presence of AF in hypertensive patients is associated with the increase of myocardial electrical inhomogeneity, with is most expressed in permanent AF: the high gradation ventricular arrhythmias in patients with uncomplicated EH, PersAF and PermAF were 5%, 28% and 62% respectively. In study population the range of corrected QT interval (QTc) of these patients, 10% in EH, 16% – PersAF and 43% – PermAF, had prolonged QTc  complexes. There were revealed correlations between dispersion of the QT interval (QTd) and parried ventricular extrasystole (r=0,26;  р<0,05), between QTd and grouped ventricular extrasystole (r=0,25;  р<0,05).

Conclusions. It was found that groups of patients associated with the increase in the frequency and amount of daily, single ventricular extrasystoles and high gradation ventricular arrhythmias a set of structural and functional changes of the heart in elderly patients with arterial hypertension and atrial fibrillation and their relation to electrical heterogeneity of the myocardium.

##plugins.themes.bootstrap3.article.details##

How to Cite
Бевзюк, Л. В., & Єна, Л. М. (2017). Analysis of indicators of 24-h holter monitoring ECG in elderly hypertensive patients with atrial fibrillation. Family Medicine, (2(70), 80–83. https://doi.org/10.30841/2307-5112.2(70).2017.115153
Section
Cardiology
Author Biographies

Л. В. Бевзюк, ГУ «Институт геронтологии имени Д.Ф. Чеботарева НАМН Украины»

L.V. Bevziuk

Л. М. Єна, ГУ «Институт геронтологии имени Д.Ф. Чеботарева НАМН Украины»

L.M. Yena

References

Гончарова А.Г., Брагин Л.Х., Воронков Ю.И., Гончаров Н.И. Циркадный индекс – предиктор соматических заболеваний // Технологии живых систем. – 2010. – Т. 7. No 2. – С. 53–55.

Ена Л.М., Кондратюк В.Е., Мудрук И.В. Артериальная гипертензия и нарушения ритма сердца // Украинский кардиологический журнал. – 2011. – No 4. – С. 108–117.

Лебедев Д.С., Михайлов Е.Н. Удлинение интервала QTc у пациентов с фибрилляцией предсердий, выявляемое при холтеровском мониторировании // Анналы аритмологии. – 2007. – Т. 4, No 3. – С. 54–59.

Национальные российские рекомендации по применению методики холтеровского мониторирования в клинической практике // Российский Кардиологический Журнал. – 2014. – Т. 2, No 106. – С. 6–71.

Пустовойтова В.А., Мартивьянова Л.А. Значение продолжительности интервала QT ЭКГ у пациентов с артериальной гипертензией // Вестник Харьковского национального университета имени В.Н. Каразина. Серия «Медицина». – 2012. – No 23.

Фурман Н.В., Шматова С.С. Клиническое значение удлинения интервалов QT и QTc на фоне приёма лекарственных препаратов // Рациональная фармакотерапия в кардиологии. – 2013. – T. 9, No 3. – С. 311–315.

ESH/ESC Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) / European Heart Journal // 2013. – V. 34. – P. 2159–2219.

Houmsse M., Tyler J., Kalbfleisch S. Supraventricular tachycardia causing heart failure // Curr. Opinion. Cardiol. – 2011. – Vol. 26, No 3. – P. 261–269.

January, C.T., Wann, L.S., Alpert, J.S., Calkins, H., Cigarroa, J.E., Cleveland, J.C. et al, 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society // J. Am. Coll. Cardiol. – 2014. – No 64. – P. 2246–2280.

Saadeh A., Evans S., James M. et al. QTc dispersion and complex ventricular arrhythmias in untreated newly presenting hypertensive patients // J. Hum. Hypertens. – 1999. – Vol. 13. – P. 665–669.

Yildirir A., Batur M.K., Oto A. Hypertension and arrhythmia: blood pressure control and beyond // Europace. – 2002. – Vol. 4. – P. 175–182.

Zhang Y., Post W.S., Dalal D. et al. QT Interval Duration and Mortality Rate. Results From the Third National Health and Nutrition Examination Survey // Arch. Intern. Med. – 2011. – Vol. 171, N 19. – Р. 1727–1733